[HTML][HTML] Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID-19 ARDS in Sorbonne hospitals, Paris
M Schmidt, E Langouet, D Hajage, SA James… - Critical Care, 2021 - Springer
Background Extracorporeal membrane oxygenation (ECMO) was frequently used to treat
patients with severe coronavirus disease-2019 (COVID-19)-associated acute respiratory …
patients with severe coronavirus disease-2019 (COVID-19)-associated acute respiratory …
Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID-19 ARDS in Sorbonne hospitals, Paris.
M Schmidt, E Langouet, D Hajage… - Critical Care (London …, 2021 - europepmc.org
Background Extracorporeal membrane oxygenation (ECMO) was frequently used to treat
patients with severe coronavirus disease-2019 (COVID-19)-associated acute respiratory …
patients with severe coronavirus disease-2019 (COVID-19)-associated acute respiratory …
Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID-19 ARDS in Sorbonne hospitals, Paris
M Schmidt, E Langouet, D Hajage, SA James… - Critical …, 2021 - search.proquest.com
Background Extracorporeal membrane oxygenation (ECMO) was frequently used to treat
patients with severe coronavirus disease-2019 (COVID-19)-associated acute respiratory …
patients with severe coronavirus disease-2019 (COVID-19)-associated acute respiratory …
[PDF][PDF] Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID-19 ARDS in Sorbonne hospitals, Paris
M Schmidt, E Langouet, D Hajage, SA James… - 2021 - scienceopen.com
Background: Extracorporeal membrane oxygenation (ECMO) was frequently used to treat
patients with severe coronavirus disease‑2019 (COVID‑19)‑associated acute respiratory …
patients with severe coronavirus disease‑2019 (COVID‑19)‑associated acute respiratory …
Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID-19 ARDS in Sorbonne hospitals, Paris
M Schmidt, E Langouet, D Hajage, SA James… - Critical Care, 2021 - inria.hal.science
Background: Extracorporeal membrane oxygenation (ECMO) was frequently used to treat
patients with severe coronavirus disease-2019 (COVID-19)-associated acute respiratory …
patients with severe coronavirus disease-2019 (COVID-19)-associated acute respiratory …
Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID-19 ARDS in Sorbonne hospitals, Paris
M Schmidt, E Langouet, D Hajage… - Critical care …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Extracorporeal membrane oxygenation (ECMO) was frequently used to treat
patients with severe coronavirus disease-2019 (COVID-19)-associated acute respiratory …
patients with severe coronavirus disease-2019 (COVID-19)-associated acute respiratory …
[PDF][PDF] Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID-19 ARDS in Sorbonne hospitals, Paris
M Schmidt, E Langouet, D Hajage, SA James… - 2021 - scholar.archive.org
Background: Extracorporeal membrane oxygenation (ECMO) was frequently used to treat
patients with severe coronavirus disease‑2019 (COVID‑19)‑associated acute respiratory …
patients with severe coronavirus disease‑2019 (COVID‑19)‑associated acute respiratory …
Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID-19 ARDS in Sorbonne hospitals, Paris.
M Schmidt, E Langouet, D Hajage, SA James… - Critical Care, 2021 - go.gale.com
Background Extracorporeal membrane oxygenation (ECMO) was frequently used to treat
patients with severe coronavirus disease-2019 (COVID-19)-associated acute respiratory …
patients with severe coronavirus disease-2019 (COVID-19)-associated acute respiratory …
Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID-19 ARDS in Sorbonne hospitals, Paris
M Schmidt, E Langouet, D Hajage, SA James… - Critical Care, 2021 - hal.science
Background: Extracorporeal membrane oxygenation (ECMO) was frequently used to treat
patients with severe coronavirus disease-2019 (COVID-19)-associated acute respiratory …
patients with severe coronavirus disease-2019 (COVID-19)-associated acute respiratory …
Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID-19 ARDS in Sorbonne hospitals, Paris
M Schmidt, E Langouet, D Hajage, SA James… - Critical …, 2021 - hal.sorbonne-universite.fr
Background: Extracorporeal membrane oxygenation (ECMO) was frequently used to treat
patients with severe coronavirus disease-2019 (COVID-19)-associated acute respiratory …
patients with severe coronavirus disease-2019 (COVID-19)-associated acute respiratory …